Browse Category

Investment Analysis News 18 December 2025

Recursion Pharmaceuticals (RXRX) Stock News & Forecast (Dec. 18, 2025): JPMorgan Upgrade, REC-4881 Trial Momentum, and What Analysts See Next

Recursion Pharmaceuticals (RXRX) Stock News & Forecast (Dec. 18, 2025): JPMorgan Upgrade, REC-4881 Trial Momentum, and What Analysts See Next

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is back in the market’s spotlight on December 18, 2025, after a sharp move higher driven by fresh Wall Street optimism and a growing pile of real-world “proof points” for the company’s AI-driven drug discovery
Broadcom (AVGO) Stock Slides on AI Funding Fears Despite Upbeat Guidance: News, Forecasts and Analyst Price Targets on Dec. 18, 2025

Broadcom (AVGO) Stock Slides on AI Funding Fears Despite Upbeat Guidance: News, Forecasts and Analyst Price Targets on Dec. 18, 2025

Broadcom Inc. (NASDAQ: AVGO) is back in the market’s spotlight on Thursday, December 18, 2025—caught in the crosswinds of two powerful narratives that don’t always play nicely together: surging AI infrastructure demand and fresh anxiety about who will finance the
1 87 88 89 90 91 230
Go toTop